| Trial ID: | L3578 |
| Source ID: | NCT02791867
|
| Associated Drug: |
Aphoelinebrake
|
| Title: |
Comparison of Laboratory Changes, Food Intake and Metabolic Profile in Patients With Obesity and Type2 Diabetes Mellitus: Before, During and After Taking AphoelineBrake
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: AphoelineBrake
|
| Outcome Measures: |
Primary: Reduction in Insulin Resistance measured by HOMA-IR, Homeostatic model assessment (HOMA) is a method for assessing β-cell function and insulin resistance (IR) from basal (fasting) glucose and insulin levels., 12 months from intervention|Reduction in glycated Haemoglobin measured: HBA1c, HbA1c refers to glycated haemoglobin. It develops when haemoglobin, joins with glucose in the blood., 12 months from intervention | Secondary: Reduction in serum triglyceride level (mmol/l), 12 months from intervention
|
| Sponsor/Collaborators: |
Sponsor: Dasman Diabetes Institute | Collaborators: University at Buffalo
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
48
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2014-12
|
| Completion Date: |
2017-07
|
| Results First Posted: |
|
| Last Update Posted: |
2018-11-27
|
| Locations: |
Dasman DIabetes Institute, Kuwait, Kuwait
|
| URL: |
https://clinicaltrials.gov/show/NCT02791867
|
